These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 3687892)

  • 1. Two new rating scales for opiate withdrawal.
    Handelsman L; Cochrane KJ; Aronson MJ; Ness R; Rubinstein KJ; Kanof PD
    Am J Drug Alcohol Abuse; 1987; 13(3):293-308. PubMed ID: 3687892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pupillometric changes during gradual opiate detoxification correlate with changes in symptoms of opiate withdrawal as measured by the Weak Opiate Withdrawal Scale.
    Rosse RB; Johri S; Goel M; Rahman F; Jawor KA; Deutsch SI
    Clin Neuropharmacol; 1998; 21(5):312-5. PubMed ID: 9789712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of the dose on the severity of opiate withdrawal symptoms during methadone detoxification.
    Glasper A; Gossop M; de Wet C; Reed L; Bearn J
    Pharmacology; 2008; 81(2):92-6. PubMed ID: 17952010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychometric evaluation of the Dutch version of the Subjective Opiate Withdrawal Scale (SOWS).
    Dijkstra BA; Krabbe PF; Riezebos TG; van der Staak CP; De Jong CA
    Eur Addict Res; 2007; 13(2):81-8. PubMed ID: 17356279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alternative strategies of opiate detoxification: evaluation of the so-called ultra-rapid detoxification.
    Scherbaum N; Klein S; Kaube H; Kienbaum P; Peters J; Gastpar M
    Pharmacopsychiatry; 1998 Nov; 31(6):205-9. PubMed ID: 9930633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Auricular acupuncture as an adjunct to opiate detoxification treatment: effects on withdrawal symptoms.
    Bearn J; Swami A; Stewart D; Atnas C; Giotto L; Gossop M
    J Subst Abuse Treat; 2009 Apr; 36(3):345-9. PubMed ID: 19004596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultra-rapid opiate detoxification using dexmedetomidine under general anesthesia.
    Nasr DA; Omran HA; Hakim SM; Mansour WA
    J Opioid Manag; 2011; 7(5):337-44. PubMed ID: 22165032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Is premature termination of opiate detoxification due to intensive withdrawal or craving?].
    Scherbaum N; Heppekausen K; Rist F
    Fortschr Neurol Psychiatr; 2004 Jan; 72(1):14-20. PubMed ID: 14745685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acetyl-L-carnitine in the management of pain during methadone withdrawal syndrome.
    Janiri L; Martinotti G; Tonioni F; Ghelardini C; Nicolai R; Galeotti N; Mosconi L; Calvani M; Bartolini A; Iannoni E
    Clin Neuropharmacol; 2009; 32(1):35-40. PubMed ID: 18978503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical characteristics of naloxone-precipitated withdrawal in human opioid-dependent subjects.
    Kanof PD; Handelsman L; Aronson MJ; Ness R; Cochrane KJ; Rubinstein KJ
    J Pharmacol Exp Ther; 1992 Jan; 260(1):355-63. PubMed ID: 1731046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of symptom complaints in methadone maintenance patients.
    Dyer KR; White JM
    Addiction; 1997 Nov; 92(11):1445-55. PubMed ID: 9519488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depression in methadone maintenance treatment patients: rate and risk factors.
    Peles E; Schreiber S; Naumovsky Y; Adelson M
    J Affect Disord; 2007 Apr; 99(1-3):213-20. PubMed ID: 17055063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement of symptom withdrawal severity in a 24-hour period after the anesthesia-assisted rapid opiate detoxification procedure.
    Teplin D; Raz B; Daiter J; Varenbut M; Zachos CT; Whang P; Herman S; Chaudry S; Yung M
    Am J Drug Alcohol Abuse; 2005; 31(2):327-35. PubMed ID: 15912719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Buprenorphine and naloxone interactions in methadone maintenance patients.
    Mendelson J; Jones RT; Welm S; Brown J; Batki SL
    Biol Psychiatry; 1997 Jun; 41(11):1095-101. PubMed ID: 9146820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intensity of opiate withdrawal in relation to the 825C>T polymorphism of the G-protein beta 3 subunit gene.
    Lieb B; Bonnet U; Specka M; Augener S; Bachmann HS; Siffert W; Scherbaum N
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Jun; 33(4):663-7. PubMed ID: 19303909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Slow-release oral morphine for maintenance treatment of opioid addicts intolerant to methadone or with inadequate withdrawal suppression.
    Kastelic A; Dubajic G; Strbad E
    Addiction; 2008 Nov; 103(11):1837-46. PubMed ID: 19032534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of buprenorphine and methadone in the treatment of opiate withdrawal: possible advantages of buprenorphine for the treatment of opiate-benzodiazepine codependent patients?
    Reed LJ; Glasper A; de Wet CJ; Bearn J; Gossop M
    J Clin Psychopharmacol; 2007 Apr; 27(2):188-92. PubMed ID: 17414244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use predicts treatment outcome, not opiate dependence or withdrawal.
    Kosten TA; Bianchi MS; Kosten TR
    NIDA Res Monogr; 1989; 95():459-60. PubMed ID: 2641030
    [No Abstract]   [Full Text] [Related]  

  • 19. [The effects of methadone maintenance in clinical opiate dependence].
    Gössling HW; Gunkel S; Wegener U; Woiton V
    Fortschr Neurol Psychiatr; 1998 Jun; 66(6):278-85. PubMed ID: 9676423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of mianserin add-on, on the intensity of opioid withdrawal symptoms during detoxification program--a randomized, double blind, placebo controlled, prospective study.
    Herman I; Shamir D; Bar-Hamburger R; Pick CG; Schreiber S
    Addict Behav; 2005 Jul; 30(6):1154-67. PubMed ID: 15925125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.